RR

Robert L. Rosati

Pfizer: 32 patents #54 of 5,153Top 2%
Overall (All Time): #114,208 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 25 most recent of 32 patents

Patent #TitleCo-InventorsDate
7521464 Pyrazole compounds for treatment of neurodegenerative disorders Yuhpyng L. Chen, Spiros Liras, Martin Patrick Allen 2009-04-21
7442702 Prostaglandin agonists Kimberly O. Cameron, Bruce Lefker 2008-10-28
7238721 Pyrazole compounds for treatment of neurodegenerative disorders Yuhpyng L. Chen, Spiros Liras, Martin Patrick Allen 2007-07-03
RE39558 5-Substituted-6-cyclic-5,6,7,8-tetrahydronaphthalen 2-ol compounds which are useful for treating osteoporosis Kimberly O. Cameron, Paul A. DaSilva Jardine 2007-04-10
6998423 Prevention of loss and restoration of bone mass by certain prostaglandin agonists Kimberly O. Cameron, Hua Zhu Ke, Bruce Lefker, David Thompson 2006-02-14
6821989 Method of treating certain cancers using an estrogen agonist/antagonist 2004-11-23
6756388 Benzothiophenes and related compounds as estrogen agonists Kimberly O. Cameron, Paul Da Silva-Jardine, Eric R. Larson, James R. Hauske 2004-06-29
6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists Kimberly O. Cameron, Hua Zhu Ke, Bruce Lefker, David Thompson 2003-11-18
6632834 Compositions and methods for treating conditions responsive to estrogen David Thompson, Andrew Lee, Wesley Day 2003-10-14
6498172 Prostaglandin agonists and their use to treat bone disorders Kimberly O. Cameron, Bruce Lefker 2002-12-24
6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists Kimberly O. Cameron, Hua Zhu Ke, Bruce Lefker, David Thompson 2002-12-10
6441193 Estrogen agonists/antagonists Kimberly O. Cameron, Paul DaSilva-Jardine, Hua Zhu Ke 2002-08-27
6426359 Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists Kimberly O. Cameron, Hua Zhu Ke, Bruce Lefker, David Thompson 2002-07-30
6376502 Osteoporosis compounds Kimberly O. Cameron, Bruce Lefker 2002-04-23
6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists Kimberly O. Cameron, Hua Zhu Ke, Bruce Lefker, David Thompson 2001-09-11
6204286 Estrogen agonists/antagonists Kimberly O. Cameron, Paul A. DaSilva Jardine 2001-03-20
6153622 Estrogen agonists/antagonists Kimberly O. Cameron, Paul DaSilva-Jardine, Hua Zhu Ke 2000-11-28
6124314 Osteoporosis compounds Kimberly O. Cameron, Bruce Lefker 2000-09-26
5703108 Bone deposition by certain prostaglandin agonists Kimberly O. Cameron, Paul DaSilva-Jardine 1997-12-30
5552412 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis Kimberly O. Cameron, Paul A. DaSilva Jardine 1996-09-03
5442044 Orally active renin inhibitors Dennis J. Hoover, Bruce Lefker 1995-08-15
5034376 Nor-statine and nor-cyclostatine polypeptides Dennis J. Hoover, Ronald T. Wester 1991-07-23
4992562 Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues Edward F. Kleinman, Jasjit S. Bindra 1991-02-12
4948913 Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues Edward F. Kleinman, Jasjit S. Bindra 1990-08-14
4935405 Nor-statine and nor-cyclostatine polypeptides Dennis J. Hoover, Ronald T. Wester 1990-06-19